Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2008-06-03
2008-06-03
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S152100, C424S155100, C424S184100, C514S002600, C514S04400A, C435S320100
Reexamination Certificate
active
07381413
ABSTRACT:
The invention involves methods of regulating cell growth and division to control disease processes by manipulating mitochondrial metabolism and the expression of cell surface immune proteins. The invention also involves related compositions and screening assays.
REFERENCES:
patent: 4724234 (1988-02-01), Cone, Jr.
patent: 4935450 (1990-06-01), Cone, Jr.
patent: 4971951 (1990-11-01), Garcia y Bellon et al.
patent: 5286653 (1994-02-01), Brenner et al.
patent: 5556754 (1996-09-01), Singer et al.
patent: 5585363 (1996-12-01), Scanlon et al.
patent: 6133946 (2000-10-01), Cavallaro et al.
patent: 6416958 (2002-07-01), Vidovic et al.
patent: 2003/0150022 (2003-08-01), Newell et al.
patent: 2004/0005291 (2004-01-01), Rogers et al.
patent: 2005/0042224 (2005-02-01), Newell
patent: 2005/0074882 (2005-04-01), Newel
patent: 2005/0158333 (2005-07-01), Newell
patent: 0524796 (1993-01-01), None
patent: WO-9716188 (1997-05-01), None
patent: WO98/02579 (1998-01-01), None
patent: WO 98/31396 (1998-07-01), None
patent: WO 98/45313 (1998-10-01), None
patent: WO 98/45438 (1998-10-01), None
patent: PCT/US99/06874 (1999-03-01), None
patent: WO 00/47617 (2000-08-01), None
patent: WO 00/78941 (2000-12-01), None
patent: WO 03/031643 (2003-04-01), None
Burrows et al. Cancer Research 52:2954 Abstract.
Arsenijevic, D. et al., “Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production”,Nature Genetics, Dec. 2000, pp. 435-439, vol. 26, No. 4.
Larrouy, D. et al., “Kupffer Cells are a Dominant Site of Uncoupling Protein 2 Expression in Rat Liver”,Biochemical and Biophysical Research Communications, 1997, pp. 760-764, vol. 235.
Pecqueur, C. et al., “Upcoupling Protein 2: in vivo distribution, induction upon oxidative stress and evidence for transitional regulation”,JBL Papers in Press Manuscript M006938200, Nov. 29, 2000, pp. 1-41, The American Society of Biochemistry and Molecular Biology, Inc.
Vidal-Puig, A.J., “Uncoupling expectations”,Nature Genetics, Dec. 2000, pp. 387-388, vol. 26, No. 4.
Street, D., et al., “Interferon-γ Enhances Susceptibility of Cervical Cancer ells to Lysis by Tumor-Specific Cytotoxic T Cells”,Gynecological Oncology, (1997), 65:265-272.
Scaffidi, et al., “Two CD95 (APO-1/Fas) Signaling Pathways”, The EMBO J., (1998), 1675-87.
Summerfield, et al., “Lymphocyte Apoptosis during Classical Swine Fever Implication of Activation-Induced Cell Death”,J Virology, (1998), 1853-1861.
Lee, J., et al., “HLA-DR-Mediated Signals for Hematopoiesis and Induction of -Apoptosis Involve But Are Not Limited to a Nitric Oxide Pathway”,Blood, (1997), 1:217-225.
Genestier, L., et al., “Caspase-dependent Ceramide Production in Fas- and HLA Class I-mediated Peripheral T Cell Apoptosis” J. Bio Chem , (1998) 5060-6.
Satoh, T., et al., “Changes in Mitochondrial Membrane Potential During Oxidative Stress-Induced Apoptosis in PC12 Cells”, J. Neuroscience Rese., (1997), 413-420.
Hermesh, O., et al., Mitochondria Uncoupling by a Long Chain Fatty Acyl Analogue,J. Bio Chem., (1998), 273:7-3937-42.
Asoh, Sadamitsu et al., “Expression of the Apoptosis-Mediator Fas. . . ”, J. Biochem., vol. 120, pp. 600-607, 1996.
Babu, P.G. et al., “Genetic Control of Multisystem Autoimmune . . . ”, Current Topics in Microbiology and Immunology, vol. 122, pp. 154-161, 1985.
Bach, Jean-Francois, “Insulin-Dependent Diabetes Mellitus as an Autoimmune Disease”, Endocrine Society, vol. 15, No. 4, pp. 516-542, Aug. 1994.
Baggetto, LG, “Deviant Energetic Metabolism of Glycolytic Cancer Cells”, Biochimie, vol. 74, pp. 959-974, 1992.
Bhushan, A. et al., “Drug Resistance Results In Alterations . . . ”, Immunology and Cell Biology 76, pp. 350-356, 1998.
Billingham, Dr. R. E. et al., “‘Actively Acquired Tolerance’ of Foreign Cells”, Nature, vol. 172, No. 4379, pp. 603-606, Oct. 3, 1953.
Birnboim, H. Chaim and Jagdeep K. Sandhu, “Levels of DNA Strand Breaks . . . ”, Journal of Cellular Biochemistry, vol. 66, pp. 219-228, 1997.
Böhme, J. et al., “Transgenic Mice with I-A on Islet Cells . . . ”, Science, vol. 244, pp. 1179-1183, Jun. 9, 1989.
Bonfoco, Emanuela et al., “Inducible Nonlymphoid Expression of Fas . . . ”, Immunity, vol. 9, pp. 711-720, Nov. 1998.
Caldwell, Kevin K. et al., “Evaluation of Methods for the Isolation . . . ”, Analytical Biochemistry, vol. 175, pp. 177-190, 1988.
Cambier, John C. et al., “Ia Binding Ligands and cAMP Stimulate Nuclear Translocation of PKC in B Lymphocytes”, Nature, vol. 327, pp. 629-632, Jun. 18, 1987.
Chien, Millie M., et al., “Fas-induced B Cell Apoptosis Requires . . . ”, Journal of Biological Chemistry, vol. 274, pp. 1-8, 1999.
Chisari, Francis V. et al., “Molecular Pathogenesis of Hepatocellular Carcinoma . . . ”, Cell, vol. 59, pp. 1145-1156, Dec. 22, 1989.
Clément, Marie-Véonique and Ivan Stamenkovic, “Superoxide Anion Is A Natural . . . ”, EMBO Journal, vol. 15, No. 2, pp. 216-225, 1996.
Conceicão-Silva, Fatima et al., “The Resolution of Lesions Induced . . . ”, Eur. J. Immunol., vol. 28, pp. 237-245, 1998.
Cosgrove, Dominic et al., “Evaluation of the Functional Equivalence of . . . ”, J. Exp. Med., vol. 176, pp. 629-634, Aug. 1992.
Cosgrove, Dominic et al., “Mice Lacking MHC Class II Molecules”, Cell, vol. 66, pp. 1051-1066, Sep. 6, 1991.
Cossarizza, Andrea et al., “Mitochondrial Modification During Rat . . . ”, Experimental Cell Research, vol. 214, pp. 323-330, 1994.
Craighead, John E. et al., “Diverse Patterns of Immune and Non-Immune . . . ”, Journal of Autoimmunity, vol. 3, (Supplement), pp. 27-29, 1990.
Creech, Elizabeth A. et al., “MHC Genes Modify Systemic Autoimmune Disease; The Role of the I-E Locus”, Journal of Immunology, vol. 156, pp. 812-817, 1996.
Dang, Chi V. and Gregg L. Semenza, “Oncogenic Alterations of Metabolism”, TIBS, vol. 24, 1999.
del Carmen Ruiz-Ruiz, Maria et al., “Activation of Protein Kinase C . . . ”, Eur. J. Immunol., vol. 27, pp. 1442-1450, 1997.
Denis-Pouxviel, Colette et al., “Regulation of Mitochondrial Hexokinase In Cultured . . . ”, Biochimica et Biophysica Acta, vol. 902, pp. 335-348, 1987.
Desbarats, Julie et al., “Fas (CD95) Expression and Death-Mediating . . . ”, Proc. Natl. Acad. Sci. USA, vol. 93, pp. 11014-11018, Oct. 1996.
Desbarats, Julie et al., “Newly Discovered Role for Fas Ligand . . . ”, Nature Medicine, vol. 4, No. 12, pp. 1377-1382, Dec. 1998.
Fleury, Christophe et al., “Uncoupling Protein-2: A Novel Gene Linked . . . ”, Nature Genetics, vol. 15, pp. 269-272, Mar. 1997.
Freedman, M., et al., vō T-cell-human glial cell interactions . . . susceptibility to cytolysis, J. Neuroimmunology, 74:143-148, 1997.
Fujihashi, Kohtaro et al., “v/ō T Cell-deficient Mice Have Impaired Mucosal Immunoglobulin A Responses,” J. Exp. Med., vol. 183, pp. 1929-1935, Apr. 1996.
Garban, Frédéric et al., “Signal Transduction Via Human Leucocyte . . . ”, Experimental Hematology, vol. 26, pp. 874-884, 1998.
Garlid, Kieth D. et al., “The Mechanism of Proton Transport . . . ”, FEBS Letters, vol. 438, pp. 10-14, 1998.
Golshani-Hebroni, Shiva G. and Samuel P. Bessman, “Hexokinase Binding to Mitochondria: A Basis . . . ”, Journal of Bioenergetics and Biomembranes, vol. 29, No. 4, pp. 331-338, 1997.
González-Barroso, M. Mar et al., “The Uncoupling Protein UCP1 Does Not . . . ”, Journal of Biological Chemistry, vol. 273, No. 25, pp. 15528-15532, Jun. 19, 1998.
Gorer, P.A., “The Genetic and Antigenic Basis of Tumour Transplantation”, Journal of Pathology, vol. XLIV, pp. 691-697.
Gray, Mi
Chan Christina
University of Vermont and State Agricultural College
VanderVegt F. Pierre
Wolf Greenfield & Sacks
LandOfFree
Methods and products related to metabolic interactions in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and products related to metabolic interactions in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and products related to metabolic interactions in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2803611